5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Nanotechnology and Cardiovascular Medicine
The use of nanoparticles is revolutionizing the way we approach heart disease, offering more targeted and effective treatments. Nanotechnology and cardiovascular medicine are becoming increasingly intertwined, providing innovative solutions for drug delivery systems that directly target affected areas of the heart. By minimizing side effects and increasing the efficacy of treatments, these advances hold significant promise. Additionally, nanotechnology is improving diagnostic capabilities, allowing for earlier detection of cardiovascular conditions with greater accuracy. As research in nanomedicine continues to progress, it opens up exciting possibilities for tissue regeneration and the development of artificial blood vessels, offering hope for those with chronic cardiovascular issues.
John R Doty
Intermountain Medical Center, United States
Trevor Tucker
Dynamic Vascular Resolution Inc., Canada
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Fatima Michelle Villa Jimenez
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico
Yoana Tenneth Mancilla Sandoval
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Surgical options for aortic valve preservation
John R Doty, Intermountain Medical Center, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Doppler ultrasound measurement of central artery elasticity: A new natural-frequency framework for cardiovascular risk assessment
Trevor Tucker, Dynamic Vascular Resolution Inc., Canada
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain